Buse Hacıoğlu

Dr. Buse Hacıoğlu

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 October 2026 in BMC Nephrology
Verified
Journal Article
Open access
PDF file
MBMesudiye Bulut
Mesudiye Bulut
YKYunus Kaya
Yunus Kaya
BHBuse Hacıoğlu
Buse Hacıoğlu
HAHadim Akoğlu
Hadim Akoğlu
Autosomal dominant polycystic kidney disease (ADPKD) is a chronic inherited disorder with renal and extrarenal manifestations that can substantially affect

11 August 2026 in BMC Nephrology
Verified
Journal Article
Open access
PDF file
NCNadir Suleyman Cetinkaya
Nadir Suleyman Cetinkaya
MBMesudiye Bulut
Mesudiye Bulut
BHBuse Hacıoğlu
Buse Hacıoğlu
ABAysenur Botsali
Aysenur Botsali
FAFATIH GOKHAN AKBAY
FATIH GOKHAN AKBAY
HAHadim Akoğlu
Hadim Akoğlu
Bullous pemphigoid (BP) is an autoimmune disease of the skin and mucous membranes. The presentation of BP as a multiple autoimmune syndrome has rarely been

1 September 2023 in Gulhane Medical Journal
Verified
Journal Article
Closed access
BHBuse Hacıoğlu
Buse Hacıoğlu
ETEmre Tekgöz
Emre Tekgöz
ITIlker Tasci
Ilker Tasci

22 May 2026 in Anatolian Current Medical Journal
Verified
Journal Article
Closed access
MBMesudiye Bulut
Mesudiye Bulut
BHBuse Hacıoğlu
Buse Hacıoğlu
FAFATIH GOKHAN AKBAY
FATIH GOKHAN AKBAY
BEBülent Erdoğan
Bülent Erdoğan
SISara İlEri
Sara İlEri
HAHadim Akoğlu
Hadim Akoğlu
Aims: Peritoneal dialysis (PD) is an effective renal replacement therapy; however, technique failure and treatment discontinuation remain major challenges. Identifying modifiable clinical and biological risk factors is essential to improve PD continuity.Methods: This single-center retrospective cohort study included 96 adult PD patients followed between January 2018 and September 2025. Patients were classified into PD continuation and dropout groups, with dropout defined as transition to hemodialysis, mortality, or permanent cessation of PD. Inflammatory indices including systemic immune-inflammation index (SII), systemic inflammation response index (SIRI), and C-reactive protein-albumin-lymphocyte (CALLY) index were calculated. Comparative analyses were performed, and multivariate logistic regression was used to identify independent predictors.Results: Among 96 patients, 54 continued PD and 31 discontinued treatment. Peritonitis was significantly more frequent in the dropout group, particularly ≥2 episodes (p=0.014). Inflammatory markers were markedly elevated in the dropout group (CRP, SII, SIRI; p